Atlas Trials

Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance

Clinical trial NCT03383822 · COMPLETED

Trial details

NCT number
NCT03383822
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Insulin Resistance
Start date
2015-09-08
Primary completion
2017-07-31
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.